Dolly Vance | Executive Vice President, Corporate Affairs and General Counsel |
Raul Rodriguez | Chief Executive Officer |
Dave Santos | Chief Commercial Officer |
Wolfgang Dummer | Chief Medical Officer |
Dean Schorno | Chief Financial Officer |
Carly Kenselaar | Citi |
Joe Pantginis | H.C. Wainwright |
Do Kim | BMO |
Kristen Kluska | Cantor Fitzgerald |
Tessa Romero | JPMorgan |
Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Third Quarter 2020. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel.